GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » PT Diagnos Laboratorium Utama Tbk (ISX:DGNS) » Definitions » COGS-to-Revenue

PT Diagnos Laboratorium Utama Tbk (ISX:DGNS) COGS-to-Revenue : 0.00 (As of . 20)


View and export this data going back to 2021. Start your Free Trial

What is PT Diagnos Laboratorium Utama Tbk COGS-to-Revenue?

PT Diagnos Laboratorium Utama Tbk's Cost of Goods Sold for the six months ended in . 20 was Rp0.00 Mil. Its Revenue for the six months ended in . 20 was Rp0.00 Mil.

PT Diagnos Laboratorium Utama Tbk's COGS to Revenue for the six months ended in . 20 was 0.00.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. PT Diagnos Laboratorium Utama Tbk's Gross Margin % for the six months ended in . 20 was N/A%.


PT Diagnos Laboratorium Utama Tbk COGS-to-Revenue Historical Data

The historical data trend for PT Diagnos Laboratorium Utama Tbk's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PT Diagnos Laboratorium Utama Tbk COGS-to-Revenue Chart

PT Diagnos Laboratorium Utama Tbk Annual Data
Trend
COGS-to-Revenue

PT Diagnos Laboratorium Utama Tbk Semi-Annual Data
COGS-to-Revenue

PT Diagnos Laboratorium Utama Tbk COGS-to-Revenue Calculation

PT Diagnos Laboratorium Utama Tbk's COGS to Revenue for the fiscal year that ended in . 20 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
= /
=

PT Diagnos Laboratorium Utama Tbk's COGS to Revenue for the quarter that ended in . 20 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
= /
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PT Diagnos Laboratorium Utama Tbk  (ISX:DGNS) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

PT Diagnos Laboratorium Utama Tbk's Gross Margin % for the six months ended in . 20 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - /
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.


PT Diagnos Laboratorium Utama Tbk COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of PT Diagnos Laboratorium Utama Tbk's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


PT Diagnos Laboratorium Utama Tbk (ISX:DGNS) Business Description

Traded in Other Exchanges
N/A
Address
Jalan Teuku Cik Ditiro 1 No. 11 A, B, C, Gedung Graha Anam, 2nd Floor, Kelurahan Gondangdia, Kecamatan Menteng, Jakarta Pusat, Jakarta, IDN, 10350
PT Main Laboratory Diagnos Tbk provides laboratory services that includes health support service activities that are managed by both the government and the private sector, such as health laboratories. The company's products and services include Service Home Service, Corporate Service, Clinical Laboratory, Genomics Laboratory, Inspection Package, Homecare Diagnos, and Examination Panel.

PT Diagnos Laboratorium Utama Tbk (ISX:DGNS) Headlines